Robert Stratta to Cytomegalovirus Infections
This is a "connection" page, showing publications Robert Stratta has written about Cytomegalovirus Infections.
Connection Strength
2.010
-
Stratta RJ, Pietrangeli C, Baillie GM. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation. Pharmacotherapy. 2010 Feb; 30(2):144-57.
Score: 0.347
-
Stratta RJ, Alloway RR, Lo A, Hodge EE. Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients. Transplant Proc. 2004 May; 36(4):1082-3.
Score: 0.233
-
Somerville T, Hurst G, Alloway R, Gaber A, Shokouh-Amiri MH, Stratta R. Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients. Transplant Proc. 1998 Jun; 30(4):1546-8.
Score: 0.155
-
Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin. Expert Opin Biol Ther. 2014 Dec; 14(12):1723-30.
Score: 0.119
-
Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC. 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation. Transplant Proc. 2014 Jul-Aug; 46(6):1928-31.
Score: 0.118
-
Stratta RJ, Taylor RJ, Bynon JS, Lowell JA, Cattral MS, Frisbie K, Miller S, Radio SJ, Brennan DC. Viral prophylaxis in combined pancreas-kidney transplant recipients. Transplantation. 1994 Feb 27; 57(4):506-12.
Score: 0.115
-
Stratta RJ. Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation. Transplant Proc. 1993 Oct; 25(5 Suppl 4):15-21.
Score: 0.112
-
Stratta RJ, Shaeffer MS, Markin RS, Wood RP, Langnas AN, Reed EC, Donovan JP, Woods GL, Bradshaw KA, Pillen TJ, et al. Cytomegalovirus infection and disease after liver transplantation. An overview. Dig Dis Sci. 1992 May; 37(5):673-88.
Score: 0.101
-
Stratta R, Shaefer M, Markin R, Bradshaw K, Donovan J, Wood R, Langnas A, Reed E, Woods G, Zetterman R, et al. Ganciclovir therapy for viral disease in liver transplant recipients. Transplant Proc. 1991 Jun; 23(3):1968.
Score: 0.095
-
Stratta RJ, Shaefer MS, Cushing KA, Markin RS, Wood RP, Langnas AN, Reed EC, Woods GL, Donovan JP, Pillen TJ, et al. Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients. Transplantation. 1991 Jan; 51(1):90-7.
Score: 0.093
-
Stratta RJ, Wood RP, Langnas AN, Duckworth RM, Shaefer MS, Marujo W, Pillen TJ, Markin RS, Shaw BW. Donor selection for orthotopic liver transplantation: lack of an effect of gender or cytomegalovirus (CMV) status. Transplant Proc. 1990 Apr; 22(2):410-3.
Score: 0.088
-
Stratta RJ, Shaefer MS, Markin RS, Wood RP, Kennedy EM, Langnas AN, Reed EC, Woods GL, Donovan JP, Pillen TJ, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg. 1989 Dec; 124(12):1443-9; discussion 1449-50.
Score: 0.086
-
Stratta RJ, Rohr MS, Adams PL, Sundberg AK, Hartmann EL, Armstrong G, Anderson TK, Farney AC, Roskopf JA, Hairston G, Kiger DF, Nagaraj SK, Iskandar SS, Assimos DG. Kidney and pancreas transplantation at Wake Forest University Baptist Medical Center. Clin Transpl. 2003; 229-45.
Score: 0.053
-
Lo A, Stratta RJ, Egidi MF, Shokouh-Amiri MH, Grewal HP, Kisilisik AT, Trofe J, Alloway RR, Gaber LW, Gaber AO. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis. Transpl Infect Dis. 2001 Mar; 3(1):8-15.
Score: 0.047
-
Lo A, Stratta RJ, Egidi MF, Kizilisik AT, Shokouh-Amiri MH, Grewal HP, Trofe J, Alloway RR, Gaber AO. Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone. Transplant Proc. 2001 Feb-Mar; 33(1-2):1796-8.
Score: 0.047
-
Egidi MF, Trofe J, Stratta RJ, Flax SD, Gaber LW, Shokouh-Amiri MH, Jones M, Vera SR, Grewal HP, Alloway RR, Gaber AO. Posttransplant lymphoproliferative disorders: single center experience. Transplant Proc. 2001 Feb-Mar; 33(1-2):1838-9.
Score: 0.047
-
Stratta RJ, Taylor RJ, Sindhi R, Sudan D, Castaldo P. Infection prophylaxis in pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3018-9.
Score: 0.033
-
Lowell JA, Stratta RJ, Morton JJ, Kolbeck PC, Taylor RJ. Invasive cytomegalovirus infection in a renal transplant ureter after combined pancreas-kidney transplantation: an unusual cause of renal allograft dysfunction. J Urol. 1994 Nov; 152(5 Pt 1):1546-8.
Score: 0.030
-
Stratta RJ, Taylor RJ, Ozaki CF, Bynon JS, Miller SA, Knight TF, Fischer JL, Neumann TV, Wahl TO, Duckworth WC, et al. A comparative analysis of results and morbidity in type I diabetics undergoing preemptive versus postdialysis combined pancreas-kidney transplantation. Transplantation. 1993 May; 55(5):1097-103.
Score: 0.027
-
Shaefer MS, Stratta RJ, Markin RS, Cushing KA, Woods GL, Reed EC, Wood RP, Langnas AN, Shaw BW. Ganciclovir therapy for cytomegalovirus disease in liver transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1515-6.
Score: 0.023
-
D'Alessandro AM, Pirsch JD, Stratta RJ, Sollinger HW, Kalayoglu M, Belzer FO. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients. Transplant Proc. 1989 Jun; 21(3):3560-1.
Score: 0.021
-
Reddy KS, Stratta RJ, Alloway RR, Lo A, Hodge EE. The impact of delayed graft function of the kidney on the pancreas allograft in simultaneous kidney-pancreas transplantation. Transplant Proc. 2004 May; 36(4):1078-9.
Score: 0.015
-
Radio SJ, Stratta RJ, Taylor RJ, Linder J. The utility of urine cytology in the diagnosis of allograft rejection after combined pancreas-kidney transplantation. Transplantation. 1993 Mar; 55(3):509-16.
Score: 0.007